Spanish experience with the ipilimumab Expanded Access Program.

被引：0
|
作者：
Berrocal, Alfonso
Lopez-Martin, Jose A.
Maria Arance, Ana
Soriano, V.
Espinosa, Enrique
Lopez Criado, M. Pilar
Munoz, Eva
Pablo Berros, Jose
Soria, A.
Marquez, I.
Sancho, P.
Gil, I.
机构：
[1] Univ Valencia, Consorcio Hosp Gen, Valencia, Spain
[2] Hosp 12 Octubre, E-28041 Madrid, Spain
[3] H Clin I Prov, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Univ La Paz, Madrid, Spain
[6] MD Anderson Madrid, Madrid, Spain
[7] H Vall dHebron, Barcelona, Spain
[8] Hosp Univ Cent Asturias IUOPA, Oviedo, Spain
[9] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[10] H Gregorio Maranon, Madrid, Spain
[11] Hosp Reina Sofia, Seville, Spain
[12] Hosp Reina Sofia, Navarra, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19023
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program
    Berrocal, Alfonso
    Arance, Ana
    Lopez Martin, Jose Antonio
    Soriano, Virtudes
    Munoz, Eva
    Alonso, Lorenzo
    Espinosa, Enrique
    Lopez Criado, Pilar
    Valdivia, Javier
    Martin Algarra, Salvador
    MELANOMA RESEARCH, 2014, 24 (06) : 577 - 583
  • [2] Ipilimumab retreatment following induction therapy: The expanded access program (EAP) experience
    Margolin, Kim Allyson
    Hamid, Omid
    Weber, Jeffrey S.
    Pavlick, Anna C.
    Hodi, F. Stephen
    Amin, Asim
    Bennett, Kelly
    Michener, Tracy
    Minor, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Ipilimumab for stage unresectable III/IV melanoma: Brazilian experience in an expanded access program
    Schmerling, Rafael
    Herchenhorn, Daniel
    Rinck, Jose Augusto
    De Camargo, Veridiana Pires
    Camargo, Johnny
    Serrano, Sergio Vicente
    Azevedo, Sergio Jobim
    Barrios, Carlos H.
    Martina Segalia, Jose Getulio
    Bertoni, Vanessa Dybal
    Buzald, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program
    Gonzalez-Cao, M.
    Arance, A.
    Piulats, J. M.
    Marquez-Rodas, I.
    Manzano, J. L.
    Berrocal, A.
    Crespo, G.
    Rodriguez, D.
    Perez-Ruiz, E.
    Berciano, M.
    Soria, A.
    Castano, A. G.
    Espinosa, E.
    Montagut, C.
    Alonso, L.
    Puertolas, T.
    Aguado, C.
    Royo, M. A.
    Blanco, R.
    Rodriguez, J. F.
    Munoz, E.
    Mut, P.
    Barron, F.
    Martin-Algarra, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (06): : 761 - 768
  • [5] Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program
    M. González-Cao
    A. Arance
    J. M. Piulats
    I. Marquez-Rodas
    J. L. Manzano
    A. Berrocal
    G. Crespo
    D. Rodriguez
    E. Perez-Ruiz
    M. Berciano
    A. Soria
    A. G. Castano
    E. Espinosa
    C. Montagut
    L. Alonso
    T. Puertolas
    C. Aguado
    M. A. Royo
    R. Blanco
    J. F. Rodríguez
    E. Muñoz
    P. Mut
    F. Barron
    S. Martin-Algarra
    Clinical and Translational Oncology, 2017, 19 : 761 - 768
  • [6] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort
    De la Rubia, Javier
    Alonso, Rafael
    Clavero Sanchez, Maria Esther
    Askari, Elham
    Garcia de Coca, Alfonso
    Maldonado, Ana
    Fernandez De la Mata, Margarita
    Escalante, Fernando
    Garcia-Feria, Ana
    Rios, Rafael
    Conesa, Venancio
    Aranzazu Bermudez, Maria
    Merchan, Beatriz
    Velasco, Alberto
    Jesus Blanchard, Maria
    Sampol, Antonia
    Gainza Gonzalez, Eukene
    Hernandez, Pedro M.
    Gonzalez-Calle, Veronica
    Alegre, Adrian
    BLOOD, 2022, 140 : 4315 - 4317
  • [7] SPANISH MELANOMA MULTIDISCIPLINARY GROUP (GEM) EXPERIENCE WITH IPILIMUMAB (IPI) IN THE EXPANDED ACCESS PROGRAMME (EAP)
    Martin Algarra, S.
    Alonso, L.
    Valdivia, J.
    Garcia Castano, A.
    Escrig, V.
    Mut, P.
    Ballesteros, A.
    Puertolas, T.
    Ortega, E.
    Berrocal, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 374 - 374
  • [8] IPILIMUMAB IN OLDER PATIENTS: SPANISH MELANOMA MULTIDISCIPLINARY GROUP (GEM) EXPERIENCE IN THE EXPANDED ACCESS PROGRAMME
    Lopez Martin, J. A.
    Gonzalez Cao, M.
    Sereno, M.
    Mayordomo, J.
    Hidalgo, M.
    Campos, B.
    Cumplido, D.
    Zambrana, F.
    Medina, J.
    Berrocal, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 374 - 375
  • [9] IPILIMUMAB IN PATIENTS WITH MELANOMA BRAIN METASTASES, A SINGLE-CENTER EXPERIENCE IN AN EXPANDED ACCESS PROGRAM
    Du Four, S.
    Wilgenhof, S.
    Neyns, B.
    NEURO-ONCOLOGY, 2012, 14 : 79 - 79
  • [10] Ipilimumab in patients with melanoma brain metastases, a single-center experience in an expanded access program
    Du Four, Stephanie
    Wilgenhof, Sofie
    Seghers, Amelie Clementine
    Duerinck, Johnny
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345